Asahi Life Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Sell |
1,280
-160
| -11% | -$52.2K | 0.24% | 94 |
|
|
2025
Q1 | $389K | Sell |
1,440
-40
| -3% | -$10.8K | 0.25% | 98 |
|
|
2024
Q4 | $348K | Sell |
1,480
-120
| -8% | -$28.2K | 0.21% | 113 |
|
|
2024
Q3 | $440K | Buy |
+1,600
| New | +$440K | 0.27% | 84 |
|
|
2024
Q2 | – | Sell |
-2,150
| Closed | -$321K | – | 151 |
|
|
2024
Q1 | $321K | Buy |
+2,150
| New | +$321K | 0.19% | 139 |
|
|
2021
Q2 | – | Sell |
-2,610
| Closed | -$369K | – | 242 |
|
|
2021
Q1 | $369K | Buy |
+2,610
| New | +$369K | 0.05% | 158 |
|
|
2020
Q3 | – | Sell |
-2,380
| Closed | -$353K | – | 235 |
|
|
2020
Q2 | $353K | Sell |
2,380
-1,720
| -42% | -$255K | 0.06% | 110 |
|
|
2020
Q1 | $446K | Buy |
4,100
+920
| +29% | +$100K | 0.08% | 93 |
|
|
2019
Q4 | $366K | Buy |
+3,180
| New | +$366K | 0.05% | 158 |
|